JP2016536348A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536348A5
JP2016536348A5 JP2016545243A JP2016545243A JP2016536348A5 JP 2016536348 A5 JP2016536348 A5 JP 2016536348A5 JP 2016545243 A JP2016545243 A JP 2016545243A JP 2016545243 A JP2016545243 A JP 2016545243A JP 2016536348 A5 JP2016536348 A5 JP 2016536348A5
Authority
JP
Japan
Prior art keywords
pyrrol
octahydrocyclopenta
hydroxy
benzyl
rac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016545243A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016536348A (ja
JP6546596B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/057800 external-priority patent/WO2015048507A1/en
Publication of JP2016536348A publication Critical patent/JP2016536348A/ja
Publication of JP2016536348A5 publication Critical patent/JP2016536348A5/ja
Application granted granted Critical
Publication of JP6546596B2 publication Critical patent/JP6546596B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016545243A 2013-09-26 2014-09-26 Nr2bの選択的オクタヒドロ−シクロペンタ[c]ピロール負調節因子 Active JP6546596B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361883050P 2013-09-26 2013-09-26
US61/883,050 2013-09-26
PCT/US2014/057800 WO2015048507A1 (en) 2013-09-26 2014-09-26 Selective octahydro-cyclopenta[c] pyrrole negative modulators of nr2b

Publications (3)

Publication Number Publication Date
JP2016536348A JP2016536348A (ja) 2016-11-24
JP2016536348A5 true JP2016536348A5 (cg-RX-API-DMAC7.html) 2017-11-24
JP6546596B2 JP6546596B2 (ja) 2019-07-17

Family

ID=52744524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016545243A Active JP6546596B2 (ja) 2013-09-26 2014-09-26 Nr2bの選択的オクタヒドロ−シクロペンタ[c]ピロール負調節因子

Country Status (9)

Country Link
US (4) US9540324B2 (cg-RX-API-DMAC7.html)
EP (2) EP3461827B1 (cg-RX-API-DMAC7.html)
JP (1) JP6546596B2 (cg-RX-API-DMAC7.html)
CN (1) CN105916843B (cg-RX-API-DMAC7.html)
AR (1) AR097794A1 (cg-RX-API-DMAC7.html)
ES (2) ES2707739T3 (cg-RX-API-DMAC7.html)
TW (1) TW201605791A (cg-RX-API-DMAC7.html)
UY (1) UY35750A (cg-RX-API-DMAC7.html)
WO (1) WO2015048507A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3461827B1 (en) 2013-09-26 2022-02-23 Cadent Therapeutics, Inc. Selective octahydro-cyclopenta[c]pyrrole negative modulators of nr2b
JO3579B1 (ar) * 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
CA2992820C (en) * 2015-08-05 2022-08-16 Indivior Uk Limited Dopamine d3 receptor antagonists having a bicyclo moiety
WO2018232158A1 (en) * 2017-06-15 2018-12-20 Belite Bio, Inc. Methods of treating metabolic diseases with fused bicyclic pyrroles
WO2020142662A1 (en) 2019-01-03 2020-07-09 Avive Solutions, Inc. Defibrillator communications architecture
IL303357A (en) * 2020-12-04 2023-08-01 Novartis Ag Dosage regimen for a nr2b-nmda receptor nam for the treatment of depression
CA3212203A1 (en) * 2021-03-26 2022-09-29 Novartis Ag Novel cyclopenta[c]pyrrol negative allosteric modulators of nr2b
EP4313042A4 (en) * 2021-03-26 2025-01-15 Novartis AG NEW CYCLOPENTA[C PYRROL NEGATIVE ALLOSTERIC MODULATORS OF NR2B

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532243A (en) 1992-02-14 1996-07-02 The Dupont Merck Pharmaceutical Company Antipsychotic nitrogen-containing bicyclic compounds
US5262564A (en) 1992-10-30 1993-11-16 Octamer, Inc. Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
DE4341403A1 (de) 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
US5541217A (en) * 1995-05-17 1996-07-30 Ortho Pharmaceutical Corporation 4-arylcyclopenta[c]pyrrole analgesics
US6369076B1 (en) * 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
EP1368354A1 (en) * 2001-03-07 2003-12-10 Pfizer Products Inc. Modulators of chemokine receptor activity
US20040242627A1 (en) 2001-04-19 2004-12-02 Shuichi Suzuki 2-Iminoimidazole derivatives (1)
JP4845873B2 (ja) * 2004-03-03 2011-12-28 ケモセントリックス インコーポレーティッド 二環式および架橋した窒素複素環
US7696241B2 (en) 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
WO2005121145A2 (en) * 2004-06-09 2005-12-22 F. Hoffmann-La Roche Ag Octahydro-pyrrolo[3,4-c] derivatives and their use as antiviral compounds
JP2008507543A (ja) 2004-07-22 2008-03-13 グラクソ グループ リミテッド 抗細菌剤
AU2006236625A1 (en) 2005-04-19 2006-10-26 Merck & Co., Inc. N-alkyl-azacycloalkyl NMDA/NR2B antagonists
EP1849772A1 (en) 2006-04-28 2007-10-31 Laboratorios Del Dr. Esteve, S.A. Bicyclic tetrahydropyrrole compounds
WO2007128458A1 (en) 2006-04-28 2007-11-15 Laboratorios Del Dr. Esteve, S.A. Bicyclic tetrahydropyrrole compounds
CN101230058A (zh) 2007-01-23 2008-07-30 上海恒瑞医药有限公司 双环氮杂烷类衍生物、其制备方法及其在医药上的用途
TW200845977A (en) 2007-03-30 2008-12-01 Targacept Inc Sub-type selective azabicycloalkane derivatives
EP2217596B8 (en) 2007-10-22 2013-11-20 Merck Sharp & Dohme Corp. Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
WO2009094866A1 (en) * 2008-01-23 2009-08-06 Shanghai Hengrui Pharmaceutical Co., Ltd. Dicycloazaalkane derivates, preparation processes and medical uses thereof
EP2378885A4 (en) 2008-12-12 2013-01-02 Univ Vanderbilt 3.3.0 BICYCLIC GLYT1 INHIBITORS AND METHOD FOR THE PRODUCTION AND USE THEREOF
FR2945533B1 (fr) * 2009-05-12 2011-05-27 Sanofi Aventis Derives de cyclopenta°c!pyrrolyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
FR2945534B1 (fr) * 2009-05-12 2012-11-16 Sanofi Aventis DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
WO2011085170A1 (en) 2010-01-07 2011-07-14 E. I. Du Pont De Nemours And Company Fungicidal heterocyclic compounds
US8796470B2 (en) 2010-05-25 2014-08-05 Abbvie Inc. Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators
WO2011149995A1 (en) * 2010-05-25 2011-12-01 Abbott Laboratories Novel substituted octahydrocyclopenta [c]pyrrol-4-amines as calcium channel blockers
US8501768B2 (en) 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
US9315518B2 (en) * 2011-06-16 2016-04-19 Merck Sharp & Dohme Corp. Imidazopyridin-2-one derivatives
JP6062432B2 (ja) * 2011-07-27 2017-01-18 ナンジン アルゲン ファルマ カンパニー リミテッドNanjing Allgen Pharma Co. Ltd. プロテインキナーゼ阻害薬用スピロ環状分子
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
SI2796460T1 (sl) 2011-12-21 2018-10-30 Jiangsu Hengrui Medicine Co. Ltd Pirolni šestčlenski derivat heteroarilnega obroča, postopek priprave zanj in medicinske uporabe le-tega
ES2753163T3 (es) * 2012-09-25 2020-04-07 Hoffmann La Roche Derivados de hexahidropirrolo[3,4-c]pirrol y compuestos relacionados como inhibidores de la autotaxina (ATX) y como inhibidores de la producción de ácido lisofosfatídico (LPA) para tratar, por ejemplo, enfermedades renales
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
EP3461827B1 (en) 2013-09-26 2022-02-23 Cadent Therapeutics, Inc. Selective octahydro-cyclopenta[c]pyrrole negative modulators of nr2b
SG11201607839UA (en) 2014-03-26 2016-10-28 Hoffmann La Roche Bicyclic compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors

Similar Documents

Publication Publication Date Title
JP2016536348A5 (cg-RX-API-DMAC7.html)
JP3930560B2 (ja) 炎症の処置のための1,2−置換イミダゾリル化合物
RU2452738C2 (ru) Соединения, модулирующие активность c-fms и/или c-kit, и их применения
RU2492167C2 (ru) Производные аминотриазола в качестве агонистов alх
JP2018535999A5 (cg-RX-API-DMAC7.html)
JP2018530591A5 (cg-RX-API-DMAC7.html)
JP2014528450A5 (cg-RX-API-DMAC7.html)
RU2010137114A (ru) Амидные производные как позитивные аллостерические модуляторы и способы их применения
CA2478156A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP2010533158A5 (cg-RX-API-DMAC7.html)
JP2010508338A5 (cg-RX-API-DMAC7.html)
JP2005511543A5 (cg-RX-API-DMAC7.html)
RU2008141509A (ru) Mglur5 модуляторы 1
JP2019537571A5 (cg-RX-API-DMAC7.html)
JP2016512515A5 (cg-RX-API-DMAC7.html)
JP2020506946A5 (cg-RX-API-DMAC7.html)
NZ609955A (en) Sgc stimulators
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
RU2011134868A (ru) N-замещенные насыщенные гетероциклические сульфоновые соединения с активностью агонистов рецептора св2
JP2017537948A5 (cg-RX-API-DMAC7.html)
RU2010146485A (ru) Новые лиганды эстрогеновых рецепторов
JP2019518036A5 (cg-RX-API-DMAC7.html)
RU2010125121A (ru) Биарилзамещенные производные азабициклических алканов
JP2017502049A5 (cg-RX-API-DMAC7.html)
JP2009504792A5 (cg-RX-API-DMAC7.html)